KGC PBM, launches micronized version of fenofibrate
Published: 2004-07-20 06:56:00
Updated: 2004-07-20 06:56:00
Korea Green Cross PBCM said it has launched in Korea Fournier's micronized version of fenofibrate, Lipidil Supra (fenofibrate) tablet, which is supplied in 160 mg. The Korean pharmaceutical market for lipid-lowering agents was worth around 10 billion won last year.
Despite its dosing reduction...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
